Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
affordable care act
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
life sciences
merck
pembrolizumab
abeona therapeutics
aducanumab
agios pharmaceuticals
alirocuma
alzheimer's
alzheimer's disease
ameet nathwani
arches
biogen
biotech
What
bio
nash
4
×
roundup
american
based
best
biogen’s
continue
crash
debate
drug
healthcare
industry
kind
news
people
pharmaceutical
policy
politicians
pressure
scalps
trump’s
u.s
aducanumab
alzheimer’s
amyloid
angst
approval
bagged
billions
biogen
biopharmaceutical
brammer
companies
convo
earlier
effects
failure
failures
felt
Language
Current search:
nash
×
" affordable care act "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More